Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP

BACKGROUND: Plasma assays for the detection of Alzheimer’s disease neuropathological changes are receiving ever increasing interest. The concentration of plasma glial fibrillary acidic protein (GFAP) has been suggested as a potential marker of astrocytes or recently, amyloid-β burden, although this...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiotis, Konstantinos, Johansson, Charlotte, Rodriguez-Vieitez, Elena, Ashton, Nicholas J., Blennow, Kaj, Zetterberg, Henrik, Graff, Caroline, Nordberg, Agneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496408/
https://www.ncbi.nlm.nih.gov/pubmed/37697307
http://dx.doi.org/10.1186/s13024-023-00647-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496408/
https://www.ncbi.nlm.nih.gov/pubmed/37697307
http://dx.doi.org/10.1186/s13024-023-00647-y

Ejemplares similares